Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes

Documenti analoghi

• The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
  di: Jae Eun So, et al.
  Pubblicazione: (2025)
• Association Between Triglyceride‐Glucose Index and Risk of Gallstone Disease: A Prospective Cohort Study of 395 391 Individuals
  di: Hongyu Li, et al.
  Pubblicazione: (2024)
• Commentary on “Association Between Triglyceride‐Glucose Index and Risk of Gallstone Disease: A Prospective Cohort Study of 395 391 Individuals”
  di: Ali Zahedian, et al.
  Pubblicazione: (2025)
• Beyond Simple Combination: Interpreting the TyG–ALT Signal Across Steatotic Liver Disease Phenotypes
  di: Minwu Wang
  Pubblicazione: (2026)
• Vitamin E in Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Stergios A. Polyzos, et al.
  Pubblicazione: (2024)